A Randomized, Placebo-Controlled Trial of Citicoline Add-On Therapy in Outpatients With Bipolar Disorder and Cocaine Dependence
The DOI matches its Crossref record; 21 of the 23 references it cites were found in a registry or an index.
Abstract
INTRODUCTION: Bipolar disorder is associated with the highest rates of substance abuse of any psychiatric disorder. Cocaine use is particularly common in patients with bipolar disorder. Both cocaine use and bipolar disorder are associated with mood symptoms and cognitive impairment. Therefore, treatments that stabilize mood, improve cognition, and reduce cocaine use would be useful. Citicoline modulates phospholipids metabolism and neurotransmitter levels and appears to improve cognition in some central nervous system disorders. A 12-week, randomized, placebo-controlled, parallel-group, add-on, proof-of-concept trial of citicoline was conducted in 44 outpatients with a history of mania or hypomania and cocaine dependence. The primary aim was to examine memory, but mood and cocaine use were also assessed. METHOD: Participants were evaluated with a structured diagnostic interview; Inventory of Depressive Symptomatology-Self-Report, Young Mania Rating Scale, and Rey Auditory Verbal Learning Test. Cocaine use was assessed with urine drug screens. Data were analyzed using mixed-model analysis of covariance, generalized estimating equations, and logistic regression analyses that used all of the available data. RESULTS: A significant group effect (P = 0.006) favoring citicoline was observed on the Rey Auditory Verbal Learning Test alternative word list. No significant between-group differences were found on the Inventory of Depressive Symptomatology-Self-Report or Young Mania Rating Scale. The citicoline group had a significantly lower probability of a cocaine-positive urine at exit (P = 0.026). The covariate-adjusted odds ratio estimate was 6.41, suggesting that those who took placebo had 6.41-times higher odds of testing positive for cocaine at exit than those who took citicoline. Citicoline was well tolerated, with no participants to our knowledge discontinuing because of medication side effects. CONCLUSIONS: The use of citicoline was associated with improvement relative to placebo in some aspects of declarative memory and cocaine use, but not mood. The findings are promising and suggest that larger trials of citicoline are warranted.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Citicoline adjunctive therapy had a positive outcome in two RCTs in patients with BD with comorbid cocaine use disorder, although the benefits of citicoline decreased over time in the more recent study (level 2).705, 706”
Citations
Cites
(1998) · The Journal of Clinical Psychiatry · Cited by 19,139
A Rating Scale for Mania: Reliability, Validity and Sensitivity
Young, R. C., Biggs, J. T., Ziegler, V. E., & Meyer, D. A. (1978) · British Journal of Psychiatry · doi:10.1192/bjp.133.5.429 · Cited by 8,744
Regier, D. A. (1990) · JAMA · doi:10.1001/jama.1990.03450190043026 · Cited by 3,962
The Inventory of Depressive Symptomatology (IDS): Psychometric properties
Rush, A. J., Gullion, C. M., Basco, M. R., Jarrett, R. B., & Trivedi, M. H. (1996) · Psychological Medicine · doi:10.1017/s0033291700035558 · Cited by 2,177
Kessler, R. C., Nelson, C. B., McGonagle, K. A., Edlund, M. J., Frank, R. G., & Leaf, P. J. (1996) · American Journal of Orthopsychiatry · doi:10.1037/h0080151 · Cited by 1,378 · cited 1×
“6% prevalence in the population.(1,2) Features of bipolar disorders can include,”
BackgroundA Randomized Efficacy Trial of Citicoline in Patients With Acute Ischemic Stroke
Clark, W. M., Williams, B. J., Selzer, K. A., Zweifler, R. M., Sabounjian, L. A., & Gammans, R. E. (1999) · Stroke · doi:10.1161/01.str.30.12.2592 · Cited by 232
Thase, M. E. (1996) · Archives of General Psychiatry · doi:10.1001/archpsyc.1996.01830090023004 · Cited by 200
Cytidine 5?-Diphosphocholine (CDP-Choline) in Stroke and Other CNS Disorders
Adibhatla, R. M., & Hatcher, J. F. (2005) · Neurochemical Research · doi:10.1007/s11064-004-9681-8 · Cited by 193
Fioravanti, M., & Yanagi, M. (2005) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000269.pub3 · Cited by 184
Drug abuse and bipolar disorder: comorbidity or misdiagnosis?
Brown, E. S., Suppes, T. M., Adinoff, B. H., & Thomas, N. R. (2001) · Journal of Affective Disorders · doi:10.1016/s0165-0327(00)00169-5 · Cited by 153
Self-citationDeclarative and procedural memory in bipolar disorder
van Gorp, W. G., Altshuler, L., Theberge, D. C., & Mintz, J. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00336-9 · Cited by 152
DIXON, C. E., MA, X., & MARION, D. W. (1997) · Journal of Neurotrauma · doi:10.1089/neu.1997.14.161 · Cited by 148
Citicoline Improves Verbal Memory in Aging
Spiers, P. A., Myers, D., Hochanadel, G. S., Lieberman, H. R., & Wurtman, R. J. (1996) · Archives of Neurology · doi:10.1001/archneur.1996.00550050071026 · Cited by 122
Antidepressant-like effects of cytidine in the forced swim test in rats
Carlezon, W. A., Pliakas, A. M., Parow, A. M., Detke, M. J., Cohen, B. M., & Renshaw, P. F. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01344-0 · Cited by 80
Osuji, I. J., & Cullum, C. M. (2005) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2005.02.005 · Cited by 76
Stoll, A. L., Sachs, G. S., Cohen, B. M., Lafer, B., Christensen, J. D., & Renshaw, P. F. (1996) · Biological Psychiatry · doi:10.1016/0006-3223(95)00423-8 · Cited by 74
Drug Abuse and Bipolar Disorders
Estroff, T. W., Dackis, C. A., Gold, M. S., & Pottash, A. L. C. (1986) · The International Journal of Psychiatry in Medicine · doi:10.2190/6d4m-j23x-l21c-tp21 · Cited by 74
Petkov, V. D., Stancheva, S. L., Tocuschieva, L., & Petkov, V. V. (1990) · General Pharmacology The Vascular System · doi:10.1016/0306-3623(90)90598-g · Cited by 47
Renshaw, P. F., Daniels, S., Lundahl, L. H., Rogers, V., & Lukas, S. E. (1999) · Psychopharmacology · doi:10.1007/s002130050871 · Cited by 46
Clinical evaluation of CDP-choline (Nicholin): efficacy As antidepressant treatment.
Salvadorini, F., Galeone, F., Nicotera, M., Ombrato, M., & Saba, P. (1975) · PubMed · Cited by 23
Effects of short-term citicoline treatment on acute cocaine intoxication and cardiovascular effects
Lukas, S. E., Kouri, E. M., Rhee, C. K., Madrid, A., & Renshaw, P. F. (2001) · Psychopharmacology · doi:10.1007/s002130100824 · Cited by 18
Cited by
Yatham, L. N., Kennedy, S. H., Parikh, S. V., Schaffer, A., Bond, D. J., Frey, B. N., Sharma, V., Goldstein, B. I., Rej, S., Beaulieu, S., et al. (2018) · Bipolar Disorders · doi:10.1111/bdi.12609 · Cited by 1,852
Yatham, L. N., Kennedy, S. H., Parikh, S. V., Schaffer, A., Beaulieu, S., Alda, M., O’Donovan, C., MacQueen, G., McIntyre, R. S., Sharma, V., et al. (2013) · Bipolar Disorders · doi:10.1111/bdi.12025 · Cited by 1,217
“In another placebocontrolled, 12-weekRCT, involving 44 patients with BD I or BD II and cocaine dependence, citicoline significantly improved some aspects of declarative memory and cocaine use, but not mood (326).”
MethodCurrent Status of Co-Occurring Mood and Substance Use Disorders: A New Therapeutic Target
Pettinati, H. M., O’Brien, C. P., & Dundon, W. D. (2013) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2012.12010112 · Cited by 252
“Only two of the six trials showed a significant reduction in substance use: one using valproate to reduce drinking (29) and the other using citicoline to reduce cocaine use (34).”
BackgroundDefining and Measuring Functional Recovery from Depression
Greer, T. L., Kurian, B. T., & Trivedi, M. H. (2010) · CNS Drugs · doi:10.2165/11530230-000000000-00000 · Cited by 222
Citicoline: pharmacological and clinical review, 2010 update.
Secades, J. J. (2011) · PubMed · Cited by 245
Metadata
- Authors
- Brown, E. S., Gorman, A. R., & Hynan, L. S.
- Affiliations
- The University of Texas Southwestern Medical Center (US)
- Corresponding author
- Brown, E. Sherwood
- Hynan, Linda S.
- Venue
- Journal of Clinical Psychopharmacology
- Published
- 2007-10
- Volume
- 27
- Issue
- 5
- Pages
- 498-502
- ISSN
- 0271-0749 (ISSN-L)
- OpenAlex
- W1983429216
- Cited by
- 79
- References
- 23
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 3 · 2023: 2 · 2022: 4 · 2021: 3 · 2020: 6 · 2019: 3 · 2018: 3 · 2017: 7 · 2016: 2 · 2015: 7 · 2014: 7 · 2013: 4 · 2012: 7
- FWCI
- 2.56
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Clinical Psychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
- Life Sciences › Neuroscience › Neurology › Neuroprotection in Cerebral Ischemia
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Keywords
- citicoline, bipolar disorder, cocaine dependence, adjunctive therapy, memory, declarative memory, cocaine use, mood, mania, hypomania, cognitive impairment, outpatients
- MeSH terms
- Adult, Affect, Bipolar Disorder, Cytidine Diphosphate Choline, Double-Blind Method, Drug Therapy, Combination, Female, Humans, Male, Memory Disorders, Middle Aged, Pilot Projects, Psychiatric Status Rating Scales, Comorbidity, Behavior, Addictive, Treatment Outcome, Diagnosis, Dual (Psychiatry), Nootropic Agents, Cocaine-Related Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.